The Next Phase: Exploring Innovation in Clinical Trials Shaping the Future of Clinical Trials: The Pivotal Role of Technology
5 snips
May 2, 2024 
Gordon Harris, Co-founder and Chief Science Officer at Yunu, leverages his expertise in medical imaging to discuss revolutionary advancements in clinical trials. He explores how technology can streamline processes, enhance global site connectivity, and improve patient access to trials. The conversation highlights the importance of interoperability and innovative platforms in addressing industry challenges. Harris also emphasizes the concept of 'naive optimism' in driving positive change and fostering creative collaboration in clinical trial innovation.
AI Snips
Chapters
Transcript
Episode notes
From Research to Clinical Tech Impact
- Dr. Gordon Harris built imaging software starting from Mass General Hospital to solve real clinical trial challenges.
- His technology evolved from in-house use to a commercial platform licensed to cancer centers and companies like UNU.
Imaging Complexity Breeds Errors
- Sites struggle managing hundreds of differing imaging criteria across trials, causing errors and inefficiencies.
- This complexity leads to costly patient enrollment mistakes and mistrust in site-based imaging reads.
Tech Streamlines and Standardizes Trials
- Technology can streamline trial workflows, improve consistency, and reduce risks for patients and sponsors.
- Standardization solves inefficiencies from paper and spreadsheet methods and risky protocol deviations.